These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 34202494)

  • 21. Emerging Evidence Highlighting the Importance of Redox Dysregulation in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS).
    Jagaraj CJ; Parakh S; Atkin JD
    Front Cell Neurosci; 2020; 14():581950. PubMed ID: 33679322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptomics and Metabolomics in Amyotrophic Lateral Sclerosis.
    Krokidis MG
    Adv Exp Med Biol; 2020; 1195():205-212. PubMed ID: 32468479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of autophagy: what can be learned from the genetic forms of amyotrophic lateral sclerosis.
    Pasquali L; Ruffoli R; Fulceri F; Pietracupa S; Siciliano G; Paparelli A; Fornai F
    CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):268-78. PubMed ID: 20406184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Iron in Amyotrophic Lateral Sclerosis.
    Bu XL; Xiang Y; Guo Y
    Adv Exp Med Biol; 2019; 1173():145-152. PubMed ID: 31456209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why do motor neurons degenerate? Actualization in the pathogenesis of amyotrophic lateral sclerosis.
    Riancho J; Gonzalo I; Ruiz-Soto M; Berciano J
    Neurologia (Engl Ed); 2019; 34(1):27-37. PubMed ID: 26853842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A prognostic biomarker in amyotrophic lateral sclerosis].
    Mitsumoto H; Saito T
    Rinsho Shinkeigaku; 2018 Dec; 58(12):729-736. PubMed ID: 30487362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis.
    Verde F; Steinacker P; Weishaupt JH; Kassubek J; Oeckl P; Halbgebauer S; Tumani H; von Arnim CAF; Dorst J; Feneberg E; Mayer B; Müller HP; Gorges M; Rosenbohm A; Volk AE; Silani V; Ludolph AC; Otto M
    J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):157-164. PubMed ID: 30309882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis.
    Scarafino A; D'Errico E; Introna A; Fraddosio A; Distaso E; Tempesta I; Morea A; Mastronardi A; Leante R; Ruggieri M; Mastrapasqua M; Simone IL
    J Neurol; 2018 Oct; 265(10):2353-2362. PubMed ID: 30116940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in genetics research in the pathogenesis of amyotrophic lateral sclerosis.
    Wang Y; Yi H; Liao Q; Bi F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 45(12):1483-1489. PubMed ID: 33473007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are Circulating Cytokines Reliable Biomarkers for Amyotrophic Lateral Sclerosis?
    Moreno-Martinez L; Calvo AC; Muñoz MJ; Osta R
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Chitotriosidase and CC-Chemokine Ligand 18 as Biomarkers of Microglia Activation in Amyotrophic Lateral Sclerosis.
    Martinez-Merino L; Iridoy M; Galbete A; Roldán M; Rivero A; Acha B; Irún P; Canosa C; Pocoví M; Mendioroz M; Jericó I
    Neurodegener Dis; 2018; 18(4):208-215. PubMed ID: 30134252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis Diagnosis.
    Mitropoulos K; Katsila T; Patrinos GP; Pampalakis G
    OMICS; 2018 Jan; 22(1):52-64. PubMed ID: 29356625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation.
    Varghese AM; Ghosh M; Bhagat SK; Vijayalakshmi K; Preethish-Kumar V; Vengalil S; Chevula PC; Nashi S; Polavarapu K; Sharma M; Dhaliwal RS; Philip M; Nalini A; Alladi PA; Sathyaprabha TN; Raju TR
    J Neuroinflammation; 2020 Aug; 17(1):232. PubMed ID: 32762702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skeletal Muscle MicroRNAs as Key Players in the Pathogenesis of Amyotrophic Lateral Sclerosis.
    Di Pietro L; Lattanzi W; Bernardini C
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29786645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron Emission Tomography Molecular Imaging Biomarkers for Amyotrophic Lateral Sclerosis.
    Chew S; Atassi N
    Front Neurol; 2019; 10():135. PubMed ID: 30881332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fungal Neurotoxins and Sporadic Amyotrophic Lateral Sclerosis.
    French PW; Ludowyke R; Guillemin GJ
    Neurotox Res; 2019 May; 35(4):969-980. PubMed ID: 30515715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel therapeutic targets for amyotrophic lateral sclerosis.
    Batra G; Jain M; Singh RS; Sharma AR; Singh A; Prakash A; Medhi B
    Indian J Pharmacol; 2019; 51(6):418-425. PubMed ID: 32029967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of Selective Autophagy Dysfunction for ALS Pathology.
    Vicencio E; Beltrán S; Labrador L; Manque P; Nassif M; Woehlbier U
    Cells; 2020 Feb; 9(2):. PubMed ID: 32046060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis.
    Ricci C; Marzocchi C; Battistini S
    Cells; 2018 Nov; 7(11):. PubMed ID: 30463376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.